Liver fibrosis in chronic hepatitis B

Clinical trials for Liver fibrosis in chronic hepatitis B explained in plain language.

Never miss a new study

Get alerted when new Liver fibrosis in chronic hepatitis B trials appear

Sign up with your email to follow new studies for Liver fibrosis in chronic hepatitis B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

Can a new pill stop liver damage in hepatitis b patients?

Disease control Not yet recruiting

This study tests a drug called hydronidone in people with liver scarring (fibrosis) from chronic hepatitis B. About 1,200 adults will take either hydronidone or a placebo, along with standard antiviral therapy, for up to 5 years. The goal is to see if hydronidone can prevent seri…

Matched conditions: LIVER FIBROSIS IN CHRONIC HEPATITIS B

Phase 3 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Disease control

Last updated Jun 27, 2026 09:06 UTC

Liver fibrosis in chronic hepatitis B

Get alerted when new Liver fibrosis in chronic hepatitis B trials appear

Can a new pill stop liver damage in hepatitis b patients?